0001179110-22-000454.txt : 20220112 0001179110-22-000454.hdr.sgml : 20220112 20220112163152 ACCESSION NUMBER: 0001179110-22-000454 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211222 FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Downing Philip A CENTRAL INDEX KEY: 0001576819 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 22526925 MAIL ADDRESS: STREET 1: C/O BIOANALYTICAL SYSTEMS, INC. STREET 2: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inotiv, Inc. CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 FORMER COMPANY: FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC DATE OF NAME CHANGE: 19970918 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2021-12-22 2021-12-30 0 0000720154 Inotiv, Inc. NOTV 0001576819 Downing Philip A C/O INOTIV, INC. 2701 KENT AVENUE WEST LAFAYETTE IN 47906 0 1 0 0 Sr. VP, Preclinical Srvcs. Common Shares 2021-12-22 4 S 0 3057 43.0412 D 40195 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.115, inclusive, to cover taxes related to the vesting of restricted stock awards. The reporting person undertakes to provide to Inotiv, Inc., any security holder of Inotiv, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This amendment is being filed solely for the purpose of correcting and supplementing the language of Footnote 1 to the original filing. Footnote 1 to the original filing described the transaction as a purchase when it was, in fact, a sale. The Footnote has also been modified to clarify that the sale was made to cover taxes related to the vesting of restricted stock awards. /s/ Beth Taylor, attorney-in-fact for Philip A. Downing 2022-01-12